Maureen T. Choman, MD

Articles

Risks and Benefits of Disease-Modifying Therapies in People Aging With Multiple Sclerosis

John R. Corboy, MD, MA;Sarah A. Morrow, MD, MS, FRCPC;Patty Bobryk, MHS, PT, MSCS, AT;Jeff Wilken, PhD;Jennifer S. Graves, MD, PhD, MAS;Ruth Ann Marrie, MD, PhD, FRCPC;Jacquelyn Bainbridge, PharmD;Renee Stewart, DNP, APRN;Rachael Stacom, NP;Mona D. Bostick, RDN, LDN;Maureen T. Choman, MD;Frederick W. Foley, PhD;Yinan Zhang, MD;Scott D. Newsome, DO, MSCS;Le H. Hua, MD

August 17th 2026

More data are needed to ascertain the actual risks and benefits of DMT use, discontinuation, and de-escalation in older people with MS.

Aging and Multiple Sclerosis: Multidisciplinary Care and Access to Care

Renee Stewart, DNP, APRN;Rachael Stacom, NP;Jacquelyn Bainbridge, PharmD;Patty Bobryk, MHS, PT, MSCS, AT;Jeff Wilken, PhD;Jennifer S. Graves, MD, PhD, MAS;Mona D. Bostick, RDN, LDN;Maureen T. Choman, MD;John R. Corboy, MD, MA;Ruth Ann Marrie, MD, PhD, FRCPC;Scott D. Newsome, DO, MSCS;Le H. Hua, MD;Sarah A. Morrow, MD, MS, FRCPC;Yinan Zhang, MD

August 3rd 2026

Multidisciplinary care for older adults with multiple sclerosis should address geriatric issues, which can be done using a comprehensive geriatric assessment by providers in disciplines including but not limited to neurology, geriatrics, rehabilitation, social work, pharmacy, neuropsychology, psychology/psychiatry, nutrition, urology, ophthalmology, and audiology.

Comorbidity, Polypharmacy, and Aging in Multiple Sclerosis

Ruth Ann Marrie, MD, PhD, FRCPC;Jacquelyn Bainbridge, PharmD;Patty Bobryk, MHS, PT, MSCS, AT;Jeff Wilken, PhD;Jennifer S. Graves, MD, PhD, MAS;Renee Stewart, DNP, APRN;Rachael Stacom, NP;Mona D. Bostick, RDN, LDN;Maureen T. Choman, MD;Frederick W. Foley, PhD;John R. Corboy, MD, MA;Scott D. Newsome, DO;Le H. Hua, MD;Yinan Zhang, MD;Sarah A. Morrow, MD, MS, FRCPC

June 29th 2026

Comprehensive care addressing issues that are common in older people with MS, including polypharmacy and comorbidity, may improve quality of life, adherence, and overall health.

Age-Related Changes in Multiple Sclerosis Pathophysiology and Clinical Function

Yinan Zhang, MD;Patty Bobryk, MHS, PT, MSCS, AT;Sarah A. Morrow, MD, MS, FRCPC;Jeff Wilken, PhD;Ruth Ann Marrie, MD, PhD, FRCPC;Jacquelyn Bainbridge, PharmD;Renee Stewart, DNP, APRN;Rachael Stacom, NP;Mona D. Bostick, RDN, LDN;Maureen T. Choman, MD;Frederick W. Foley, PhD;John R. Corboy, MD, MA;Scott D. Newsome, DO, MSCS;Le H. Hua, MD;Jennifer S. Graves, MD, PhD, MAS

May 18th 2026

Understanding age-related changes in multiple sclerosis (MS) may help inform treatment decisions that address normal aging and MS-related aging processes.